(19)
(11) EP 4 739 309 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24742643.0

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
A61K 31/401(2006.01)
A61P 25/28(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/401; A61K 9/0019; A61K 9/0043; A61P 25/28
(86) International application number:
PCT/GB2024/051728
(87) International publication number:
WO 2025/008625 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.07.2023 GB 202310195

(71) Applicant: Cambridge Enterprise Limited
Cambridge, Cambridgeshire CB2 1TN (GB)

(72) Inventors:
  • RAHMAN, Saifur
    Cambridge Cambridgeshire CB3 0GT (GB)
  • HASTINGS, Nataly
    Cambridge Cambridgeshire CB3 0GT (GB)

(74) Representative: Potter Clarkson 
Chapel Quarter Mount Street
Nottingham NG1 6HQ
Nottingham NG1 6HQ (GB)

   


(54) DANEGAPTIDE FOR USE IN TREATING SYNUCLEINOPATHIES